JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: ENMD-2076 (ENMD2076) is a novel, potent and orally bioactive inhibitor of multikinase including Aurora A and Flt3 with potential antitumor activity. It inhibits Aurora A and Flt3 with IC50s of 14 nM and 1.86 nM, respectively, and exhibits 25-fold selectivity for Aurora A over Aurora B. It shows potent in vitro antiproliferative activity and high in vivo antitumor efficacy.
References: Mol Cancer Ther. 2011 Jan; 10(1):126-37; 17(24):7614-24; Br J Haematol. 2010 Aug; 150(3):313-25.
Related CAS #: 1291074-87-7 (tartrate); 1453868-32-0 (tartrate); 934353-76-1 (free base);
Synonym: ENMD 2076; ENMD-2076; ENMD2076.
Chemical Name: (E)-N-(5-methyl-1H-pyrazol-3-yl)-6-(4-methylpiperazin-1-yl)-2-styrylpyrimidin-4-amine.
InChi Key: BLQYVHBZHAISJM-CMDGGOBGSA-N
InChi Code: InChI=1S/C21H25N7/c1-16-14-20(26-25-16)23-19-15-21(28-12-10-27(2)11-13-28)24-18(22-19)9-8-17-6-4-3-5-7-17/h3-9, 14-15H, 10-13H2, 1-2H3, (H2, 22, 23, 24, 25, 26)/b9-8+
SMILES Code: CN1CCN(C2=CC(NC3=NNC(C)=C3)=NC(/C=C/C4=CC=CC=C4)=N2)CC1
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!